A new computational system called Schemonic, developed by Cornell researchers, cuts the costs of using large language models such as ChatGPT and Google Bard by combing large datasets and generating what amounts to “CliffsNotes” versions of data.
Cornell AI News
News Category
Health and Medicine
Filter by Topic
Diagnostic tool identifies puzzling inflammatory diseases in kids
A Cornell-led collaboration developed machine-learning models that use these cell-free molecular RNA dregs to diagnose pediatric inflammatory conditions that are difficult to differentiate. The diagnostic tool can accurately determine if a patient has Kawasaki disease (KD), Multisystem Inflammatory Syndrome in Children (MIS-C), a viral infection or a bacterial infection, while simultaneously monitoring the patient’s organ health.
AI boosts indoor food production’s energy sustainability
Integrating artificial intelligence into today’s environmental control systems could reduce energy consumption for indoor agriculture by 25% – potentially helping to feed the world as its population rises, Cornell engineers have found.
Study finds potential link between DNA markers and aging
Researchers have uncovered DNA markers associated with retroelements, remnants of ancient viral genetic material, in our genes that act as highly accurate epigenetic clocks predicting chronological age.
Cognitive behavioral therapy app improves anxiety in young adults
Researchers at Weill Cornell Medicine and NewYork-Presbyterian found that a self-guided cognitive behavioral therapy app significantly reduced anxiety in young adults struggling with mental health challenges.
SciAI Center, Pasteur Labs partner to reshape human-AI collaboration
Cornell Engineering’s Scientific Artificial Intelligence Center has partnered with Pasteur Labs, an alumnus-founded startup, to establish new research projects in human-AI collaboration for scientific discovery and industrial applications.
Machine learning helps define subtypes of Parkinson’s disease
Researchers at Weill Cornell Medicine have used machine learning to define three subtypes of Parkinson’s disease based on the pace at which the disease progresses.
Jamey Edwards ’96 MBA ’03 is on a mission to fix healthcare
The newest episode of the Startup Cornell podcast features Jamey Edwards ’96 MBA ’03, president & chief strategy officer at Koko Home, a company providing radar driven, AI-enabled solutions for healthcare and an Entrepreneur in Residence of StartUp Health, which was founded in 2011 to invest in global health entrepreneurs.